Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PAVmed (PAVM) Preferred Dividend Payments (2017 - 2025)

PAVmed has reported Preferred Dividend Payments over the past 5 years, most recently at $91000.0 for Q4 2025.

  • For Q4 2025, Preferred Dividend Payments rose 137.3% year-over-year to $91000.0; the TTM value through Dec 2025 reached $355000.0, up 7200.0%, while the annual FY2025 figure was $356000.0, N/A changed from the prior year.
  • Preferred Dividend Payments for Q4 2025 was $91000.0 at PAVmed, up from $90000.0 in the prior quarter.
  • Over five years, Preferred Dividend Payments peaked at $91000.0 in Q4 2025 and troughed at -$244000.0 in Q4 2024.
  • A 5-year average of $60000.0 and a median of $75000.0 in 2021 define the central range for Preferred Dividend Payments.
  • Biggest five-year swings in Preferred Dividend Payments: tumbled 412.82% in 2024 and later skyrocketed 137.3% in 2025.
  • Year by year, Preferred Dividend Payments stood at $67000.0 in 2021, then rose by 7.46% to $72000.0 in 2022, then rose by 8.33% to $78000.0 in 2023, then tumbled by 412.82% to -$244000.0 in 2024, then skyrocketed by 137.3% to $91000.0 in 2025.
  • Business Quant data shows Preferred Dividend Payments for PAVM at $91000.0 in Q4 2025, $90000.0 in Q3 2025, and $88000.0 in Q2 2025.